Evidence map›Paper›PMID 36114563›Full record

ArticleEuropean journal of medical research2022

Clinical significance of

Wen Du, Guojin Cui, Kaiping Wang, Shaojie Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Cancers · 2026
    Article
  3. [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Observational
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Wen DuDepartment of Nuclear Medicine, Da Qing Oilfield General Hospital, No.9 Zhongkang street, Daqing City, 163001, Heilongjiang, China. wend_2021@163.com.
Guojin CuiDepartment of Nuclear Medicine, Da Qing Oilfield General Hospital, No.9 Zhongkang street, Daqing City, 163001, Heilongjiang, China.
Kaiping WangDepartment of Nuclear Medicine, Da Qing Oilfield General Hospital, No.9 Zhongkang street, Daqing City, 163001, Heilongjiang, China.
Shaojie LiDepartment of Nuclear Medicine, Da Qing Oilfield General Hospital, No.9 Zhongkang street, Daqing City, 163001, Heilongjiang, China.
Daqing Oilfield General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore the clinical significance of

methodsThis study is a clinical retrospective study. The research subjects were patients with GIST who were admitted to our hospital from January 2014 to December 2019 and underwent

resultsA total of 32 patients with GIST were included in this study, of which 17 patients had very low and low-risk lesions, and the FDG metabolism level did not increase; five patients had moderate-risk gastric lesions, and the FDG metabolism level was abnormally increased; 10 patients had high-risk lesions, and except for one patient with multiple lesions, the FDG metabolism level of these patients was increased.

conclusionsThe level of glucose metabolism is abnormally increased in tumor cells with vigorous mitosis and has higher biological risk. The

Indexed as

Fluorodeoxyglucose F18Gastrointestinal Stromal TumorsGlucoseHumansPositron Emission Tomography Computed TomographyRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18GlucoseRadiopharmaceuticals18F-FDG metabolic imagingGastrointestinal stromal tumorGlucose metabolism levelRetrospective studyTumor

Identifiers

PMID36114563
PMCPMC9479238
OpenAlexW4296041624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.